Less Ads, More Data, More Tools Register for FREE

Pin to quick picksRedcentric Regulatory News (RCN)

Share Price Information for Redcentric (RCN)

Share Price is delayed by 15 minutes
Get Live Data
123.50    1.50 (1.24%)
Bid:
121.00
Ask:
123.50
Spread: 2.50 (2.066%)
Market Cap: £196.76m
RCN Live PriceLast checked at - London Stock Exchange

Intraday Redcentric Share Chart

Director/PDMR Shareholding

23 Dec 2020 07:00

RNS Number : 6037J
Redcentric PLC
23 December 2020
 

Redcentric plc

 

Director/PDMR Shareholding, Issue of Equity and Total Voting Rights

 

Redcentric plc (AIM: RCN) ("Redcentric" or the "Company"), a leading UK IT managed services provider, announces that on 22 December 2020 it received notification of exercise from each of Peter Brotherton, Chief Executive Officer, and David Senior, Chief Financial Officer, in relation to nil-cost share options ("Options") over ordinary shares of 0.1p each in the Company ("Ordinary Shares"), pursuant to the Company's 2017 Long Term Incentive Plan (the "Exercise"), as follows:

· Peter Brotherton exercised 192,481 Options. Following the Exercise, Mr Brotherton sold 97,481 Ordinary Shares at a price of 110 pence per Ordinary Share on 22 December 2020 in order to cover the tax and national insurance liability associated with the Exercise. Following the Exercise and the sale of shares, Mr Brotherton holds 228,571 Ordinary Shares in the Company (representing approximately 0.15% of the Company's issued share capital) and 921,061 share options in the Company;

· David Senior exercised 29,100 Options. Following the Exercise, Mr Senior sold 14,550 Ordinary Shares at a price of 110 pence per Ordinary Share on 22 December 2020 in order to cover the tax and national insurance liability associated with the Exercise. Following the Exercise and the sale of shares, Mr Senior holds 43,121 Ordinary Shares in the Company (representing approximately 0.03% of the Company's issued share capital) and 249,555 shares options in the Company.

Accordingly, application has been made for 221,581 new Ordinary Shares to be issued pursuant to the option exercise to be admitted to trading on AIM ("Admission"). Admission is expected to occur at 8.00 a.m. on or around the 31 December 2020.

Following Admission, the Company's issued share capital will consist of 156,165,710 Ordinary Shares, 37,569 of which are held in Treasury. For reporting under the FCA's Disclosure Guidance and Transparency Rules, shareholders should exclude any shares held in Treasury and should use the figure of 156,128,141 Ordinary Shares (the issued voting share capital) when determining if they are required to notify their interest, or a change of their interest in the Company.

Following the Exercise there are options outstanding over 3,891,750 Ordinary Shares, representing 2.49% of the Company's issued share capital.

Enquiries:

Redcentric plc

Peter Brotherton, Chief Executive Officer

David Senior, Chief Financial Officer

 

+44 (0)800 983 2522

finnCap Ltd - Nomad and Sole Broker

Marc Milmo / Simon Hicks / Charlie Beeson (Corporate Finance)

Andrew Burdis / Sunila de Silva (ECM)

+44 (0)20 7220 0500

The notifications below, made in accordance with the requirements of the Market Abuse Regulation, provide further detail.

Notification and public disclosure of transactions by persons discharging managerial responsibilities and persons closely associated with them 

 

1.

Details of the person discharging managerial responsibilities / person closely associated

a)

Name

Peter Brotherton

 

2.

Reason for the Notification

a)

Position/status

Chief Executive Officer

b)

Initial notification/Amendment

Initial notification

3.

Details of the issuer, emission allowance market participant, auction platform, auctioneer or auction monitor

a)

Name

Redcentric plc

b)

LEI

213800FGYMMNE9OKFD14

4.

Details of the transaction(s): section to be repeated for (i) each type of instrument; (ii) each type of transaction; (iii) each date; and (iv) each place where transactions have been conducted

a)

Description of the Financial instrument, type of instrument

Ordinary Shares of 0.1p

Identification code

RCN GB00B7TW1V39

b)

Nature of the transaction

- Exercise of options granted under the Redcentric plc 2017 Long Term Incentive Plan

- Sale of ordinary shares

c)

Price(s) and volume(s)

Price(s)

Volume(s)

Date of transaction(s)

Nil cost

192,481 options exercised

22 December 2020

110p

97,481 ordinary shares sold

22 December 2020

 

 

d)

Aggregated information:

· Aggregated volume

· Price

See 4 (c) above

e)

Date of the transactions

See 4 (c) above

f)

Place of the transaction

London Stock Exchange, AIM Market (XLON)

 

1.

Details of the person discharging managerial responsibilities / person closely associated

a)

Name

David Senior

 

2.

Reason for the Notification

a)

Position/status

Chief Financial Officer

b)

Initial notification/Amendment

Initial notification

3.

Details of the issuer, emission allowance market participant, auction platform, auctioneer or auction monitor

a)

Name

Redcentric plc

b)

LEI

213800FGYMMNE9OKFD14

4.

Details of the transaction(s): section to be repeated for (i) each type of instrument; (ii) each type of transaction; (iii) each date; and (iv) each place where transactions have been conducted

a)

Description of the Financial instrument, type of instrument

Ordinary Shares of 0.1p

Identification code

RCN GB00B7TW1V39

b)

Nature of the transaction

- Exercise of options granted under the Redcentric plc 2017 Long Term Incentive Plan

- Sale of ordinary shares

c)

Price(s) and volume(s)

Price(s)

Volume(s)

Date of transaction(s)

Nil cost

29,100 options exercised

22 December 2020

110p

14,550 ordinary shares sold

22 December 2020

 

 

d)

Aggregated information:

· Aggregated volume

· Price

See 4 (c) above

e)

Date of the transactions

See 4 (c) above

f)

Place of the transaction

London Stock Exchange, AIM Market (XLON)

 

 

This information is provided by RNS, the news service of the London Stock Exchange. RNS is approved by the Financial Conduct Authority to act as a Primary Information Provider in the United Kingdom. Terms and conditions relating to the use and distribution of this information may apply. For further information, please contact rns@lseg.com or visit www.rns.com.RNS may use your IP address to confirm compliance with the terms and conditions, to analyse how you engage with the information contained in this communication, and to share such analysis on an anonymised basis with others as part of our commercial services. For further information about how RNS and the London Stock Exchange use the personal data you provide us, please see our Privacy Policy.
 
END
 
 
DSHTTBJTMTTTTPM
Date   Source Headline
12th Jul 20227:00 amRNSAcquisition of Sungard data centres and 4D
7th Jul 20226:25 pmRNSCompletion of Acquisitions
21st Jun 20227:00 amRNSDirector/PDMR Shareholding
9th Jun 20227:00 amRNSDirector/PDMR Shareholding
7th Jun 20228:07 amRNSAcquisition of business and assets of Sungard
12th May 20227:00 amRNSDirectorate Change
28th Apr 20227:00 amRNSTrading Update
27th Apr 20227:00 amRNSNew £100m Bank Facilities
21st Apr 20227:00 amRNSExercise of Options
17th Mar 20227:00 amRNSExercise of Options
15th Mar 20227:00 amRNSAcquisition of 7 Elements Limited
24th Feb 202211:29 amRNSTransaction in Own Shares
21st Feb 20227:00 amRNSHolding(s) in Company
15th Feb 20227:00 amRNSTransaction in Own Shares
14th Feb 20227:00 amRNSResponse to outcome of FCA criminal prosecutions
2nd Feb 20221:43 pmRNSHolding(s) in Company
2nd Feb 20227:00 amRNSTransaction in Own Shares
19th Jan 20227:00 amRNSTransaction in Own Shares
19th Jan 20227:00 amRNSHolding(s) in Company
14th Jan 20227:00 amRNSTransaction in Own Shares
10th Jan 20227:00 amRNSTransaction in Own Shares
6th Jan 20227:00 amRNSTransaction in Own Shares
5th Jan 20227:00 amRNSTransaction in Own Shares
4th Jan 20227:00 amRNSTransaction in Own Shares
31st Dec 202112:27 pmRNSHolding(s) in Company
30th Dec 20217:00 amRNSTransaction in Own Shares
29th Dec 20217:00 amRNSHolding(s) in Company
24th Dec 20217:00 amRNSTransaction in Own Shares
23rd Dec 20214:48 pmRNSSave As You Earn Option Scheme
17th Dec 20218:22 amRNSNotice of subscription of warrants
24th Nov 20216:20 pmRNSDirector/PDMR Shareholding and Issue of Equity
22nd Nov 20215:30 pmRNSDividend Update
19th Nov 20217:00 amRNSGrant of Options and Director/PDMR Shareholding
18th Nov 20217:01 amRNSHalf Year Results
18th Nov 20217:00 amRNSBoard changes
8th Nov 20212:58 pmRNSHolding(s) in Company
27th Oct 20217:00 amRNSTrading Update
20th Oct 20217:00 amRNSIssue of Equity
12th Oct 20217:00 amRNSExercise of Options
5th Oct 20217:00 amRNSIssue of Equity
30th Sep 20217:00 amRNSAcquisition of Piksel Industry Solutions Limited
29th Sep 20217:00 amRNSExercise of Options
9th Sep 20214:11 pmRNSResult of AGM
31st Aug 20217:00 amRNSSave As You Earn Share Option Scheme
9th Aug 20217:00 amRNSPublication of Annual Report and Notice of AGM
26th Jul 20217:00 amRNSIssue of Equity
23rd Jul 20212:55 pmRNSHolding(s) in Company
23rd Jul 202111:26 amRNSHolding(s) in Company
15th Jul 20217:00 amRNSPreliminary Results Announcement FY21
8th Jul 20217:00 amRNSBoard Change

Due to London Stock Exchange licensing terms, we stipulate that you must be a private investor. We apologise for the inconvenience.

To access our Live RNS you must confirm you are a private investor by using the button below.